The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adorini, L.
Right arrow Articles by Momburg, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adorini, L.
Right arrow Articles by Momburg, F.

The Journal of Immunology, Vol 151, Issue 7 3576-3586, Copyright © 1993 by American Association of Immunologists


ARTICLES

Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II- restricted T cells

L Adorini, JC Guery, S Fuchs, V Ortiz-Navarrete, GJ Hammerling and F Momburg
Preclinical Research, Sandoz Pharma Ltd., Basel, Switzerland.

To study the processing and presentation of endogenously synthesized Ag to class II MHC-restricted T cells, hen egg lysozyme (HEL), either tagged with a peptide that confers retention in the endoplasmic reticulum (HEL.KDEL), or in the secretory form (HELs), was stably expressed in LK-35.2 B hybridoma cells. Presentation of HEL peptides bound to class II molecules was assessed by activation of specific T cell hybridomas recognizing seven different epitopes derived from exogenous HEL. The presentation of endogenously synthesized HEL was not caused by reuptake of secreted of shed Ag. All the HEL epitopes examined were efficiently presented after processing of endogenous HEL by HELs-transfected LK-35.2 cells. Processing of HEL tagged with KDEL, however, gave rise to presentation of only six of the seven HEL epitopes. The epitope included in the HEL sequence 112-124 was not presented by HEL.KDEL-transfected B cells. In addition, two of the four T cell hybridomas recognizing HEL 116-129 together with I-Ak molecules were not activated by HEL.KDEL, and three other epitopes were presented with lower efficiency as compared with HELs. Thus, endogenously synthesized HEL in secretory form gives rise to a set of class II- binding epitopes indistinguishable from exogenous HEL, whereas endoplasmic reticulum-retained HEL generates a similar but not identical set of epitopes. The endosomal protease inhibitor leupeptin prevented presentation of the epitope 108-116, but not 46-61, both by HELs and HEL.KDEL transfected cells, indicating a requirement for endosomal processing in both cases. In addition, the presentation of peptides derived from endogenously synthesized, either secretory or endoplasmic reticulum-retained HEL, could be inhibited by lysosomotropic amines, further indicating that the intracellular route of class II molecules presenting peptides derived from endogenous Ag intersects the acidic endosomal compartment.


This article has been cited by other articles:


Home page
BloodHome page
K. R. Qazi, U. Gehrmann, E. Domange Jordo, M. C. I. Karlsson, and S. Gabrielsson
Antigen-loaded exosomes alone induce Th1-type memory through a B cell-dependent mechanism
Blood, March 19, 2009; 113(12): 2673 - 2683.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. C. Wheeler, M. Rizzi, R. Sasik, G. Almanza, G. Hardiman, and M. Zanetti
KDEL-Retained Antigen in B Lymphocytes Induces a Proinflammatory Response: A Possible Role for Endoplasmic Reticulum Stress in Adaptive T Cell Immunity
J. Immunol., July 1, 2008; 181(1): 256 - 264.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. P. Dolan, K. D. Gibbs Jr., and S. Ostrand-Rosenberg
Tumor-Specific CD4+ T Cells Are Activated by "Cross-Dressed" Dendritic Cells Presenting Peptide-MHC Class II Complexes Acquired from Cell-Based Cancer Vaccines
J. Immunol., February 1, 2006; 176(3): 1447 - 1455.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. K. Dissanayake, N. Tuera, and S. Ostrand-Rosenberg
Presentation of Endogenously Synthesized MHC Class II-Restricted Epitopes by MHC Class II Cancer Vaccines Is Independent of Transporter Associated with Ag Processing and the Proteasome
J. Immunol., February 15, 2005; 174(4): 1811 - 1819.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Martinez-Soria, N. Ibnou-Zekri, M. Iwamoto, M.-L. Santiago-Raber, S. Kikuchi, M. Kosco-Vilbois, and S. Izui
Epitope-Dependent Inhibition of T Cell Activation by the Ea Transgene: An Explanation for Transgene-Mediated Protection from Murine Lupus
J. Immunol., August 15, 2004; 173(4): 2842 - 2848.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. H. Koonce, G. Wutz, E. J. Robertson, A. B. Vogt, H. Kropshofer, and E. K. Bikoff
DM Loss in k Haplotype Mice Reveals Isotype-Specific Chaperone Requirements
J. Immunol., April 1, 2003; 170(7): 3751 - 3761.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Qi and S. Ostrand-Rosenberg
H2-O Inhibits Presentation of Bacterial Superantigens, but Not Endogenous Self Antigens
J. Immunol., August 1, 2001; 167(3): 1371 - 1378.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Rinaldi, F. Ria, P. Parrella, E. Signori, A. Serra, S. A. Ciafrè, I. Vespignani, M. Lazzari, M. G. Farace, G. Saglio, et al.
Antibodies Elicited by Naked DNA Vaccination against the Complementary-determining Region 3 Hypervariable Region of Immunoglobulin Heavy Chain Idiotypic Determinants of B-lymphoproliferative Disorders Specifically React with Patients' Tumor Cells
Cancer Res., February 1, 2001; 61(4): 1555 - 1562.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
E. M. Janssen, A. J. M. van Oosterhout, F. P. Nijkamp, W. van Eden, and M. H. M. Wauben
The Efficacy of Immunotherapy in an Experimental Murine Model of Allergic Asthma Is Related to the Strength and Site of T Cell Activation During Immunotherapy
J. Immunol., December 15, 2000; 165(12): 7207 - 7214.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Qi, J.-M. Rojas, and S. Ostrand-Rosenberg
Tumor Cells Present MHC Class II-Restricted Nuclear and Mitochondrial Antigens and Are the Predominant Antigen Presenting Cells In Vivo
J. Immunol., November 15, 2000; 165(10): 5451 - 5461.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
P. Guermonprez, R. Lo-Man, C. Sedlik, M.-J. Rojas, R. J. Poljak, and C. Leclerc
mAb against hen egg-white lysozyme regulate its presentation to CD4+ T cells
Int. Immunol., November 1, 1999; 11(11): 1863 - 1872.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Panjwani, O. Akbari, S. Garcia, M. Brazil, and B. Stockinger
The HSC73 Molecular Chaperone: Involvement in MHC Class II Antigen Presentation
J. Immunol., August 15, 1999; 163(4): 1936 - 1942.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. Volkmann, T. Barthlott, S. Weiss, R. Frank, and B. Stockinger
Antagonist Peptide Selects Thymocytes Expressing a Class II Major Histocompatibility Complex-restricted T Cell Receptor into the CD8 Lineage
J. Exp. Med., September 21, 1998; 188(6): 1083 - 1089.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Accapezzato, R. Nisini, M. Paroli, G. Bruno, F. Bonino, M. Houghton, and V. Barnaba
Generation of an MHC Class II-Restricted T Cell Epitope by Extracellular Processing of Hepatitis {delta} Antigen
J. Immunol., June 1, 1998; 160(11): 5262 - 5266.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Deussing, W. Roth, P. Saftig, C. Peters, H. L. Ploegh, and J. A. Villadangos
Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation
PNAS, April 14, 1998; 95(8): 4516 - 4521.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Badou, M. Savignac, M. Moreau, C. Leclerc, R. Pasquier, P. Druet, and L. Pelletier
HgCl2-induced Interleukin-4 Gene Expression in T Cells Involves a Protein Kinase C-dependent Calcium Influx through L-type Calcium Channels
J. Biol. Chem., December 19, 1997; 272(51): 32411 - 32418.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. A. Villadangos, R. J. Riese, C. Peters, H. A. Chapman, and H. L. Ploegh
Degradation of Mouse Invariant Chain: Roles of Cathepsins S and D and the Influence of Major Histocompatibility Complex Polymorphism
J. Exp. Med., August 18, 1997; 186(4): 549 - 560.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.